Methotrexate 55150-0513
Product NDC
55150-0513- Manufacturer
- Eugia Us Llc
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intrathecal, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 11, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA201529
Need to source Methotrexate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methotrexate Sodium | 250 mg/10mL |
Drug Class
Folate Analog Metabolic Inhibitor [EPC]Folic Acid Metabolism Inhibitors [MoA]
Packaging Options(1)
1 VIAL in 1 CARTON (55150-513-01) / 10 mL in 1 VIAL